Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.2900
+0.0150 (5.45%)
Nov 9, 2026, 10:47 AM EST
Anebulo Pharmaceuticals Employees
As of June 30, 2025, Anebulo Pharmaceuticals had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year. That makes Anebulo Pharmaceuticals the 42,813th largest employer in the world and 6,799th in the United States.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
11.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 3 | 0 | - | 2 | 1 |
| Jun 30, 2024 | 3 | 1 | 50.00% | 2 | 1 |
| Jun 30, 2023 | 2 | -2 | -50.00% | 2 | 0 |
| Jun 30, 2022 | 4 | 1 | 33.33% | 4 | 0 |
| Jun 30, 2021 | 3 | - | - | 2 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Zeo ScientifiX | 33 |
| Brainstorm Cell Therapeutics | 19 |
| Inhibitor Therapeutics | 8 |
| Hepion Pharmaceuticals | 2 |
| Vicapsys Life Sciences | 2 |
| Synlogic | 1 |
Anebulo Pharmaceuticals News
- 8 months ago - Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates - Business Wire
- 8 months ago - Anebulo Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 8 months ago - Anebulo Pharmaceuticals Earnings release: Q2 2026 - Filings
- 9 months ago - Anebulo Pharmaceuticals to voluntarily delist from Nasdaq - TheFly
- 9 months ago - Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC - Business Wire
- 9 months ago - Anebulo Pharmaceuticals Announces Final Results of Tender Offer - Business Wire
- 9 months ago - Anebulo Pharmaceuticals Announces Preliminary Results of Tender Offer - Business Wire
- 10 months ago - Anebulo announces cash tender offer of 300,000 shares at $3.50 per share - TheFly